Optina Diagnostics’ options allow specialists and main care physicians to diagnose continual ailments including Alzheimer’s with dependable and exact retinal scans.
SAN ANTONIO, Aug. 30, 2022 /PRNewswire/ — Based on its current evaluation of the North American Hyperspectral Retinal Imaging Industry, Frost & Sullivan acknowledges Optina Diagnostics with the 2022 Technology Innovation Leadership Award for providing refined synthetic intelligence (AI)-powered Retinal Deep Phenotyping™ options. Optina Diagnostics’ complete expertise facilitates early and non-invasive diagnostic exams for continual ailments including neurodegenerative situations with its extremely differentiated hyperspectral retinal imaging digicam, the Optina-4C™, considerably bettering commonplace medical practices.
The firm is engaged on an AI-driven Retinal Deep Phenotyping™ resolution to detect continual illness biomarkers, which might improve the prognosis of neurodegenerative situations comparable to Alzheimer’s. Optina Diagnostics is growing its awAIr™ cerebral amyloid standing take a look at to facilitate the dependable and early detection of Alzheimer’s illness.
“The awAIr™ cerebral amyloid status test, the first application of the Retinal Deep Phenotyping™ platform that combines AI and the Optina-4C™, will equip physicians and neuro specialists with the necessary tools for an early and accurate diagnosis of Alzheimer’s disease in the office or clinic. These specialists will be able to run rapid amyloid status tests on patients during their regular clinical evaluations and then deliver automated same-day results. Eye specialists can adopt the platform to support neuro specialists and primary care physicians in their diagnostic process by performing safe and non-invasive retinal scans. “Identifying Alzheimer’s illness because the underlying reason for reminiscence loss and cognitive impairment will permit physicians to develop a greater sufferers care map by offering sufferers with higher high quality of life plans and therapy choices,” mentioned Dr. Sneha Maria, Industry Analyst at Frost & Sullivan.
“The awAIr™ cerebral amyloid standing take a look at, subsequently, will increase the accessibility of Alzheimer’s illness diagnostics with exact early-stage prognosis earlier than onset of signs. The Retinal Deep Phenotyping™ platform offers probably the most data-rich retinal imaging data and excels in knowledge high quality.
Optina Diagnostics builds AI algorithms for the exact phenotypic characterization of ailments. The firm plans to develop a number of AI-driven exams for quite a few continual ailments. Additionally, Optina Diagnostics is partnering with the pharmaceutical business to implement the Optina-4C™ digicam and collaborate on new research and novel biomarkers. As a outcome, the corporate is quickly rising and delivering unmatched improvements to the market.
The firm is about to rework the panorama of diagnostics in lots of different continual ailments by offering entry to novel and unprecedented diagnostic knowledge for investigation,” noted Maria. “Frost & Sullivan considers the potential of Optina-4C™ and the AI-driven Retinal Deep Phenotyping™ platform as disruptive and noteworthy; the expertise has the potential to diagnose a number of systemic ailments at an early stage via easy, non-invasive, cost-effective, and simply accessible retinal imaging.”
In addition to contributing to a affected person’s care, specialists and main care physicians can broaden their clinic service choices to new illness areas.
Each 12 months, Frost & Sullivan presents this award to the corporate that has developed a product with revolutionary options and performance that’s rapidly gaining market acceptance. The award acknowledges the standard of the answer and the added worth it brings to the shoppers.
Frost & Sullivan’s Best Practices awards acknowledge corporations in varied regional and international markets for demonstrating excellent achievement and superior efficiency in management, technological innovation, customer support, and strategic product improvement. Industry analysts examine market members and measure efficiency via in-depth interviews, analyses, and intensive secondary analysis to determine greatest practices within the business.
For six many years, Frost & Sullivan has been world-renowned for its function in serving to traders, company leaders, and governments navigate financial modifications and determine disruptive applied sciences, Mega Trends, new business fashions, and corporations to motion, leading to a steady circulate of development alternatives to drive future success. Contact us: Start the dialogue.
Contact:
Bianca Torres
P: 1.210.247.8860
E: [email protected]
Optina harnesses the ability of revolutionary retinal imaging and AI, within the type of a One-second eye scan, to offer accessible, non-invasive diagnostic take a look at outcomes for silent and under-detected ailments, empowering healthcare suppliers and sufferers to behave on well timed and significant data. www.OptinaDx.com.
Logo – https://mma.prnewswire.com/media/1887465/Optina_Diagnostics_Award_Logo.jpg
